- Stocks
- Pharma & Healthcare
- Bajaj Healthcare
Bajaj Healthcare share price
NSE: BAJAJHCAREPharma & HealthcareDrug Manufacturers - Specialty & Generic
Bajaj Healthcare at a glance
Bajaj Healthcare (NSE: BAJAJHCARE) closed at ₹327.65 on 22 Oct 2026, up 1.13% on the day. With a market capitalisation of ₹1,103 Cr, it ranks 1407th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
At its last close the stock traded at 48.6× trailing earnings, against a return on equity of 8.5% in FY25. Over the past year the share price has fallen 28.5%. Its 52-week range is ₹272.35 (18 May 2026) to ₹488.90 (30 Oct 2025); the last close is 33.0% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹166 Cr (+11.3% year on year) and net profit ₹14 Cr (+15.8%), on a standalone basis. Promoters held 58.59% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹1,103 CrRank 1407 on NSE
- P/E (trailing)
- 48.6×
- Price to book
- 4.55×FY25
- EPS (TTM)
- ₹5.40to Q1 FY27
- ROE
- 8.5%FY25
- ROCE
- 13.8%FY25
- Debt to equity
- 0.48FY25
- Net profit margin
- 7.3%FY25
- Book value / share
- ₹147.60FY25
- Dividend payout
- 7.0%FY25
- 52-week high
- ₹488.9030 Oct 2025
- 52-week low
- ₹272.3518 May 2026
- 1-year return
- −28.5%
- RSI (14-day)
- 48
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | +1.13% | −0.7% | −2.1% | +1.8% | −28.5% |
Bajaj Healthcare quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹133 Cr | ₹123 Cr | ₹154 Cr | ₹149 Cr | ₹148 Cr | ₹161 Cr | ₹153 Cr | ₹166 Cr |
| Revenue YoY | +31.5% | +13.1% | +15.4% | +12.5% | +11.1% | +31.3% | −0.9% | +11.3% |
| Net profit | ₹9 Cr | ₹12 Cr | ₹11 Cr | ₹12 Cr | ₹11 Cr | ₹16 Cr | −₹23 Cr | ₹14 Cr |
| Net profit YoY | — | — | — | +65.9% | +17.4% | +33.7% | −304.4% | +15.8% |
| Net margin | 7.1% | 9.5% | 7.2% | 7.9% | 7.5% | 9.7% | −14.9% | 8.3% |
| EPS | ₹3.36 | ₹3.65 | ₹3.54 | ₹3.74 | ₹3.53 | ₹4.96 | −₹7.16 | ₹4.07 |
Bajaj Healthcare financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹410 Cr | ₹657 Cr | ₹680 Cr | ₹673 Cr | ₹473 Cr | ₹543 Cr |
| Operating profit | ₹32 Cr | ₹119 Cr | ₹90 Cr | ₹58 Cr | ₹28 Cr | ₹46 Cr |
| Net profit | ₹23 Cr | ₹83 Cr | ₹71 Cr | ₹43 Cr | −₹84 Cr | ₹40 Cr |
| EPS (₹) | ₹16.31 | ₹60.23 | ₹25.87 | ₹15.59 | −₹30.36 | ₹13.29 |
| Cash from operations | ₹21 Cr | ₹44 Cr | ₹1 Cr | −₹22 Cr | ₹92 Cr | ₹22 Cr |
| Total debt | ₹24 Cr | ₹80 Cr | ₹66 Cr | ₹94 Cr | ₹39 Cr | ₹65 Cr |
| Shareholders' equity | ₹152 Cr | ₹258 Cr | ₹328 Cr | ₹368 Cr | ₹278 Cr | ₹466 Cr |
Bajaj Healthcare shareholding pattern
| Holder | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 25 Mar 2026 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 59.19% | 59.19% | 59.19% | 58.29% | 58.29% | 58.59% |
| Foreign institutions | 1.09% | 1.12% | 1.18% | 1.53% | 1.98% | 2.19% |
| Domestic institutions | 3.16% | 3.00% | 2.96% | 2.91% | 2.91% | 1.92% |
| Non-institutions | 36.56% | 36.70% | 36.67% | 37.27% | 36.82% | 37.30% |
Bajaj Healthcare vs peers
The listed Pharma & Healthcare companies nearest to Bajaj Healthcare by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| SHALBYShalby | ₹118.16 | −1.53% | −52.1% | ₹1,276 Cr | 36.5 | — |
| GPTHEALTHGPT Healthcare | ₹135.22 | −0.86% | −8.2% | ₹1,110 Cr | 26.3 | — |
| BAJAJHCAREBajaj Healthcare | ₹327.65 | +1.13% | −28.5% | ₹1,103 Cr | 48.6 | — |
| BAFNAPHBafna Pharmaceuticals | ₹451.95 | −2.00% | +195.6% | ₹1,069 Cr | 96.4 | — |
| LINCOLNLincoln Pharmaceuticals | ₹517.50 | +0.10% | −0.9% | ₹1,037 Cr | 11.8 | — |
| SIGACHISigachi Industries | ₹26.24 | −0.08% | −30.3% | ₹1,003 Cr | — | — |
| LAXMIDENTLLaxmi Dental | ₹177.55 | −0.25% | −43.4% | ₹976 Cr | 33.7 | — |
Ask anything about Bajaj Healthcare
Pivot answers on the live chart with evidence you can check, and tests strategies against BAJAJHCARE's own history. Try: “Why has BAJAJHCARE moved over the last three months?” · “Backtest a 50-day moving-average crossover on BAJAJHCARE over five years” · “Compare BAJAJHCARE with SHALBY on margins and valuation”
Frequently asked questions about Bajaj Healthcare
What is the share price of Bajaj Healthcare today?
Bajaj Healthcare (NSE: BAJAJHCARE) last closed at ₹327.65 on 22 Oct 2026. Its 52-week high is ₹488.90 and its 52-week low is ₹272.35.
What is the market cap of Bajaj Healthcare?
Bajaj Healthcare's market capitalisation is ₹1,103 Cr (₹1,103 Cr) at the 22 Oct 2026 close, ranking 1407th among the NSE companies Pivot tracks.
What is the P/E ratio of Bajaj Healthcare?
Bajaj Healthcare trades at a trailing P/E of 48.6. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 33.7.
What is the ROE and ROCE of Bajaj Healthcare?
Return on equity was 8.5% in FY25 and return on capital employed was 13.8% in FY25 (standalone figures).
Is Bajaj Healthcare a debt-free company?
No. Bajaj Healthcare's debt-to-equity ratio was 0.48 in FY25, with total debt of ₹65 Cr.
What were Bajaj Healthcare's latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Bajaj Healthcare reported revenue of ₹166 Cr, +11.3% year on year, and net profit of ₹14 Cr, +15.8% year on year.
How has Bajaj Healthcare stock performed over the last year?
Bajaj Healthcare's share price has fallen 28.5% over the past year, +1.8% over three months and −2.1% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Bajaj Healthcare?
As of 30 Jun 2026: promoters 58.59%, foreign institutions 2.19%, domestic institutions 1.92%, non-institutions 37.30%.
Who are Bajaj Healthcare's competitors?
The listed Pharma & Healthcare companies closest to Bajaj Healthcare by market cap are Shalby, GPT Healthcare, Bafna Pharmaceuticals, Lincoln Pharmaceuticals, Sigachi Industries and Laxmi Dental.
Is Bajaj Healthcare a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Bajaj Healthcare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on BAJAJHCARE against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with B · all NSE stocks · this page as text